Resmed (RSMDF) Share-based Compensation (2009 - 2026)

Resmed (RSMDF) has reported Share-based Compensation for 18 consecutive years, with $27.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation rose 10.94% year-over-year to $27.5 million; the trailing twelve-month figure through Jun 2026 stood at $104.3 million (up 13.84% YoY), and the FY2026 full-year result was $104.3 million, up 13.84% from the prior year.
• Share-based Compensation advanced to $27.5 million in Q2 2026 per RSMDF's latest filing, from $26.8 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $28.9 million in Q4 2025 and bottomed at $2.3 million in Q1 2022.
• Historically, Share-based Compensation has averaged $20.1 million across 5 years, with a median of $20.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation slumped 85.55% in 2022, then soared 691.48% in 2023.
• Over 5 years, Share-based Compensation stood at $16.5 million in 2022, then rose by 20.51% to $19.8 million in 2023, then climbed by 14.08% to $22.6 million in 2024, then advanced by 27.85% to $28.9 million in 2025, then retreated by 5.11% to $27.5 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $27.5 million, $26.8 million, and $28.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.